J David Grainger

Affiliations

  • Chief Innovation Officer at Centessa Pharmaceuticals Plc (CNTA), 2024-01-03
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CNTA $9.05 27,500 $248,754.00 27,500 2022-01-28 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CNTA $3.95 2,853 $11,269.64 908,575 2022-10-03 Filing
CNTA $4.07 2,328 $9,468.91 911,428 2022-09-30 Filing